Track Descriptors

Description: This track will encompass all aspects of fundamental HIV biology and the host response to HIV. Areas of focus will include HIV infection and replication, transmission, genetics, evolution, structure and function, pathogenesis, adaptive and innate immune responses to HIV, genetic susceptibility to HIV, interaction of micronutrients, co -infection and progress in animal models. Pre-clinical vaccine, microbicide, and drug development will be important themes of this track.

HIV evolution, viral diversity and bioinformatics
A1. HIV-1/2: Origins, evolution, diversity and response to ARV
A2. Molecular epidemiology of HIV diversity
A3. Bioinformatics analysis of HIV diversity and drug resistance
Immunology of HIV
A4. Innate immune responses and function in natural history of HIV infection
A5. Humoral immune responses and function in natural history of HIV infection
A6. Cellular immune responses and function in natural history of HIV infection
A7. Immune responses in resistant cohorts: elite controllers and exposed uninfected
Transmission and Pathogenesis (HIV-1/2)
A8. Viral determinants of HIV pathogenesis
A9. Acute and early HIV infection
A10. Animal models of transmission, disease resistance and progression
A11. HIV transmission (mucosal and mother to child transmission; other transmission)
A12. Ageing and HIV
Host genetics and HIV infections
A13. Host genetics of resistance and susceptibility and restriction factors
HIV: Co-infections and emerging pathogens
A14. HIV super-infection
A15. HIV co-infection with TB and other pathogens (Hepatitis B, C, HPV...)
A16. HIV interactions with emerging and other opportunistic pathogens
HIV: Drug development and resistance
A17. HIV drug development: Synthetic, traditional and microbicides
A18. Molecular mechanisms of drug action and antiviral drug resistance and drug interaction
A19. Nucleic acid based HIV and SIV therapies
A20. Targeting and HIV persistence during ART (cure strategies)
Vaccine development
A21. Clinical trials in HIV vaccine development
A22. Animal models for vaccine development
Interaction of micronutrients and HIV infection
A23. Effect of micronutrients in HIV and AIDS pathogenesis, transmission and treatment
A24. Mechanisms of micronutrient and HIV interactions
Diagnostics tools development (for use in resource limited settings)
A25. Novel assays of immune responses in HIV and AIDS
A26. Novel assays and cost effectiveness tools for virological monitoring
A27. Rapid and cost-effective HIV screening and diagnostic methods
A28. HIV drug resistance testing
Characterization of HIV latency and viral reservoirs
A29. Measurement of HIV/SIV reservoirs
A30. Host cellular latency
A31. Targeting and eradication of reservoirs



Twitter Feed

Memory of ICASA

  • ICASA 2017